Detalhe da pesquisa
1.
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies.
Cancer Immunol Immunother
; 70(10): 2737-2750, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830275
2.
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens.
Haematologica
; 105(4): 1032-1041, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31296574
3.
Recent Advancements and Applications of Human Immune System Mice in Preclinical Immuno-Oncology.
Toxicol Pathol
; 48(2): 302-316, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31847725
4.
Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized mice.
Front Immunol
; 14: 1107848, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36936963
5.
The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status.
Haematologica
; 102(11): e447-e451, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838994
6.
3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma.
Cancers (Basel)
; 13(7)2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33804934
7.
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma.
Leukemia
; 35(9): 2635-2649, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731849
8.
Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy-induced cytokine release syndrome.
Clin Transl Immunology
; 9(11): e1202, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173582
9.
PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax.
Blood Adv
; 4(17): 4217-4231, 2020 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898249
10.
The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 23(6): 1493-1505, 2017 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27637890
11.
Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).
Clin Cancer Res
; 20(13): 3458-71, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24799524